BPS Program Book 2014

Author Disclosures

Authors of submitted abstracts completed a disclosure statement. Disclosures included any relationships that may bias one’s presentation or which, if known, could give the perception of bias. These situations include but are not limited to: 1. Stock options or bond holdings in a for-profit corporation or self-directed pension plan 2. Research funded by industry grant 3. Employment (full- or part-time) in funding company 4. Ownership or Partnership in funding organization 5. Consulting fees or other remuneration from industry 6. Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson in company 7. Receipt of royalties from referenced company products 8. Speaker’s bureau 9. Other Below is the list of authors and disclosures for programmed abstracts.

Name

Disclosure Entity

Disclosure Type

Presentation Number

Abdeladim, Lamiae Ackerman, Michael J.

Phasics

Employment (full or part-time) in funding company 2904-Pos

Other/Royalties (significant or > 10 K but < 50K/year category) – Transgenomic

Other

2798-Pos

Ainla, Alar

Co-founder of Avalance Biotech AB Stock options or bond holdings in a for-profit corporation or self-directed pension plan

1055-Pos

Akeson, Mark

Oxford Nanopore Technologies

Consulting fees or other remuneration from industry 1083-Pos Employment (full or part-time) in funding company 2904-Pos Employment (full or part-time) in funding company 3041-Pos Employment (full or part-time) in funding company 3045-Pos

Aknoun, Sherazade Aknoun, Sherazade Aknoun, Sherazade Alexander, Leila T. Alkhamici, Heba Alvarenga, Érika C.

Phasics

PHASICS S.A. PHASICS S.A.

Structural Genomics Consortium Research funded by industry grant

108-Plat

SDx Tethered Membranes Pty Ltd Employment (full or part-time) in funding company 1500-Pos

INCT

Other

1554-Pos

Amodaj, Nenad

Aratome LLC MyoKardia Inc

Ownership or Partnership in funding organization 2012-Pos

Anderson, Robert L.

Stock options or bond holdings in a for-profit corporation or self-directed pension plan Stock options or bond holdings in a for-profit corporation or self-directed pension plan

3692-Pos

Appleby, Todd

Gilead Sciences Inc.

1330-Pos

Aussenac, Fabien Bammes, Benjamin

Bruker

Employment (full or part-time) in funding company 2228-Plat Employment (full or part-time) in funding company 3031-Pos

Driect Electron

Barauskas, Ona

Gilead Sciences Inc.

Stock options or bond holdings in a for-profit corporation or self-directed pension plan

1330-Pos

Barker, Oliver Bayley, Hagan

Evotec (UK) Ltd

Employment (full or part-time) in funding company 90-Plat

Oxford Nanopore Technologies

Stock options or bond holdings in a for-profit corporation or self-directed pension plan

108-Plat

Bechinger, Burkhard

Bruker - CNRS PhD grant to H. Sarrouj

Research funded by industry grant

2228-Plat

290

Biophysical Society 58 th Annual Meeting, San Francisco, California